Mario Gabelli Lexicon Pharmaceuticals, Inc. Transaction History

Gamco Investors, Inc. Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$1.2 - $6.66 $26,400 - $146,520	-22,000 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$4.36 - $7.94 $8,720 - $15,880	2,000 Added 10.0%	22,000 $122,000
Q3 2018 Nov 02, 2018	BUY	$10.32 - $13.06 $41,280 - $52,240	4,000 Added 25.0%	20,000 $213,000
Q2 2018 Aug 10, 2018	BUY	$7.8 - $13.69 $6,240 - $10,952	800 Added 5.26%	16,000 $192,000
Q1 2018 May 09, 2018	BUY	$7.86 - $11.39 $4,716 - $6,834	600 Added 4.11%	15,200 $130,000
Q3 2017 Nov 01, 2017	BUY	$12.17 - $16.3 $177,682 - $237,980	14,600	14,600 $179,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.